Arvinas (ARVN) Depreciation and Depletion (2017 - 2025)
Arvinas' (ARVN) quarterly Depreciation and Depletion came in at $700000.0 in Q1 2025, down 41.67% year-on-year from $1.2 million in Q1 2024, and down 41.67% quarter-over-quarter from $1.2 million in Q1 2024.
Arvinas (ARVN) Depreciation and Depletion (2017 - 2025) Analysis & Trends
Arvinas' Depreciation and Depletion history runs 5 years deep, the most recent figure standing at $700000.0 for Q1 2025.
- On a quarterly basis, Depreciation and Depletion fell 41.67% year-over-year to $700000.0 in Q1 2025; TTM through Mar 2025 was $2.4 million, a 27.33% increase from a year earlier, with the FY2024 full-year figure at $4.6 million, down 4.17% from the prior year.
- Depreciation and Depletion declined to $700000.0 in Q1 2025 per ARVN's latest filing, from $1.2 million in the prior quarter.
- Across five years, Depreciation and Depletion topped out at $1.2 million in Q1 2024 and bottomed at $700000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 196,658.72 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 39.39 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 2.20 Mn |
| 10 | Arvinas | 519.68 Mn | -95.22 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 700,000.00 |
| Mar 31, 2025 | 700,000.00 |
| Mar 31, 2024 | 1.20 Mn |
| Mar 31, 2024 | 1.20 Mn |
| Mar 31, 2019 | 246,158.00 |
| Mar 31, 2019 | 246,158.00 |
| Dec 31, 2018 | 222,948.00 |
| Dec 31, 2018 | 222,948.00 |
| Sep 30, 2018 | 191,547.00 |
| Sep 30, 2018 | 191,547.00 |
| Mar 31, 2018 | 123,028.00 |
| Mar 31, 2018 | 123,028.00 |
| Dec 31, 2017 | 101,028.00 |
| Dec 31, 2017 | 101,028.00 |
| Sep 30, 2017 | 92,147.00 |
| Sep 30, 2017 | 92,147.00 |